ABI-02

N/A

Report date: 2024/09/27 09:46:20
NME

Base Information

Drug NameABI-02
Drug Alias NameABI-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDYRK kinase inhibitors
TargetsDYRK kinase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvanti Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvanti Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A